Bank of America
ALT icon

Bank of America’s Altimmune ALT Stock Holding History

Bank of America’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-350,000
Closed -$1.48M – 7689
2023
Q1 		$1.48M Buy
350,000
+250,000
+250% +$2.97M ﹤0.01% 4610
2022
Q4 		$1.65M Hold
100,000
– – ﹤0.01% 4425
2022
Q3 		$1.28M Buy
+100,000
New +$1.48M ﹤0.01% 4685

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of America's ALT Position: Q1 2026 in Review

Bank of America increased its Altimmune (ALT) stake by 49% in Q1 2026, buying an estimated $792K and bringing the position to 570,203 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #4201.

Bank of America first reported a position in ALT in Q2 2014 and has held it in 39 quarters since. The position peaked at $8.71M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Bank of America held 570,203 shares of Altimmune worth $1.76M as of Q1 2026.
  • Bank of America bought 186,420 Altimmune shares in Q1 2026, an estimated $792K.
  • Altimmune made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4201 holding.
  • Bank of America first reported a position in Altimmune in Q2 2014 and has held it in 39 quarters since.
  • Bank of America's Altimmune position peaked at $8.71M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.